DAXOR

Daxor is a global leader in blood volume measurement technology, focusing on innovations in blood volume testing. We have developed and marketed the BVA-100® (Blood Volume Analyzer), the first diagnostic blood test approved by the U.S. Food and Drug Administration, which can safely, accurately, and objectively quantify blood volume status and components compared to patient-specific norms. More than 60,000 tests have been conducted at leading hospital centers across the United States, improving performance metrics for hospitals under various surgical and medical conditions, including significantly reducing mortality and readmission rates for heart failure and intensive care. With support from the National Institutes of Health, Daxor is conducting several ongoing multicenter trials in the fields of COVID-19 and heart failure treatment, and has signed a contract with the U.S. Department of Defense to develop analytical instruments to improve combat casualty care. Daxor's mission is to promote healthcare by achieving optimal fluid management through blood volume analysis.